Cutaneous IgG4-related disease treated with dupilumab

Cutaneous IgG4-related disease treated with dupilumab

We present a 59-year-old male with a prolonged history of severe, treatment-resistant pruritic dermatosis and associated systemic symptoms, including fatigue and diarrhea. Dermatologic examination revealed widespread erythematous-brownish papules and nodules, prompting a skin biopsy that showed dens...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mafalda Pestana, Alexandre João, Susana Palma-Carlos, Paula Leiria-Pinto, Ana L. João
Format:	Article
Language:	English
Published:	Sociedade Portuguesa de Dermatologia e Venereologia 2025-04-01
Series:	Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Subjects:	Immunoglobulin G4-related disease. Cutaneous. Dupilumab.
Online Access:	https://www.portuguesejournalofdermatology.com/frame_eng.php?id=217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect Of Aegle marmelos on IgM And IgG Antibody Titers in Rattus norvegicus
by: Kadeq Novita Prajawanti, et al.
Published: (2023-09-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Relationship between renal deposition of complement C3， IgG， IgM and pathology in IgA nephropathy
by: Fang-cao Lu, et al.
Published: (2022-08-01)

Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review
by: Cristina Guerriero, et al.
Published: (2025-07-01)

Ophthalmic Manifestations of Immunoglobulin G4-Related Disease (IgG4-RD)
by: Ayushi Agarwal, et al.
Published: (2021-07-01)

Keratoacanthoma-like eruption associated with pembrolizumab and dupilumab treated by intralesional triamcinolone: A case report
by: Raphaella Lambert, BA, et al.
Published: (2025-07-01)

The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency
by: Selime Özen Bölük, et al.
Published: (2023-06-01)

High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01)

Determination of Immunoglobulin's levels in cutaneous Leishmainasis patients
by: Nuha S. Al-Bayatii, et al.
Published: (2023-02-01)

IgG Biomarkers in Multiple Sclerosis: Deciphering Their Puzzling Protein A Connection
by: Leonard Apeltsin, et al.
Published: (2025-03-01)

Cervical myelopathy caused by IgG4-related hypertrophic spinal pachymeningitis: Case report and a descriptive review of the literature
by: Ahmet Parlak, et al.
Published: (2024-01-01)

IgG-Associated Hypocomplementemia in Neonatal Lupus: A Retrospective Multicenter Study
by: Sun W, et al.
Published: (2025-03-01)

Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
by: Andrew R. Crowley, et al.
Published: (2023-12-01)

IgG4 Licks base of skull, wastes tongue: An unusual presentation
by: Shekhar Dorle, et al.
Published: (2021-01-01)

Dermatitis herpetiformis successfully treated with dupilumab
by: Sara Al-Khawaga, MD, PhD, et al.
Published: (2025-07-01)

Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
by: Lingyu Hu, et al.
Published: (2023-07-01)

Comparison of IgG4 with inflammatory cytokines (IL-1, IL-6 and TNFα) in rheumatoid arthritis
by: Rajalingham Sakthiswary, et al.
Published: (2025-07-01)

IgG4-Related Disease in Childhood: Clinical Presentation, Management, and Diagnostic Challenges
by: Silvia Taranto, et al.
Published: (2025-07-01)

The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients
by: Akemi Hara, et al.
Published: (2025-07-01)

Case Report: Cutaneous T-cell lymphoma associated with biologic therapy: three cases and a literature review
by: Tingting Li, et al.
Published: (2025-04-01)

Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations [version 2; peer review: 2 approved]
by: Henry Karanja, et al.
Published: (2025-07-01)

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
by: Tomohito Takeshige, et al.
Published: (2024-12-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
by: Imam Nurjaya, et al.
Published: (2024-10-01)

A novel methodology for the extraction, purification and characterization of immunoglobulin G (IgG) nanoparticles from bovine colostrum: implications for food and therapeutic industries
by: Fawze Alnadari, et al.
Published: (2025-09-01)

T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab
by: Davender Redhu, et al.
Published: (2025-05-01)

IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression
by: Hui Wang, et al.
Published: (2025-01-01)

Positive rates of hepatitis E virus IgG antibodies in pregnant women in China: a meta-analysis
by: Qixin XIE, et al.
Published: (2025-02-01)

Seroprevalence of Immunoglobulin G Levels (IgG) against Varicella in Healthy Indian Adults: A Cross-sectional Study
by: Huidrom Manimohon Singh, et al.
Published: (2025-01-01)

Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China
by: Yue Xu, et al.
Published: (2025-07-01)

Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series
by: Sunny B. Patel, et al.
Published: (2025-04-01)

Dupilumab and atopic march; Reduction of incident allergic events or Clinical control?
by: Jorge Sánchez, et al.
Published: (2024-12-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

Predictive value of serum IgG/C3 levels for membranous nephropathy in diabetics with proteinuria and negative phospholipase A2 receptor antibody
by: Huan Wang, et al.
Published: (2024-12-01)

Toll-like receptors 2 and 4, and bacterial proteins in IgG4-related sialadenitis, other types of chronic sialadenitis and sialolithiasis
by: Elin Waltimo, et al.
Published: (2024-12-01)

CT Coronary Angiogram in Diagnosing IgG4 of Coronary Arteries Presenting as Acute Coronary Syndrome: A Case Report with Review of Literature
by: Apratim Roy Choudhury, et al.
Published: (2025-07-01)

Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
by: Maura C. Gillis, BA, et al.
Published: (2025-02-01)

Successful treatment of scleromyxedema with dupilumab: A case report
by: Abdulelah Alghamdi, MBBS, et al.
Published: (2025-09-01)

A pediatric case of dupilumab-induced pustular psoriasis
by: Nan Dang, et al.
Published: (2024-12-01)